New CEOs at Ax­o­vant, Des­tiny and Organo­vo mark a busy week for the biotech jobs scene

Peer Re­view is the week­ly bio­phar­ma jobs re­port from End­points News.

→ Mus­cu­loskele­tal com­pa­ny Flex­ion Ther­a­peu­tics $FLXN said co-founder Neil Bod­ick will tran­si­tion to CSO from CMO. Yamo Deniz be­comes CMO. Deniz was VP and glob­al head of med­ical for rare dis­eases at the Gen­zyme unit of Sanofi.

→ Rare dis­eases play PTC Ther­a­peu­tics $PTCT said CFO Shane Ko­vacs will leave the com­pa­ny in mid-May. PTC is seek­ing a re­place­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.